Rgl-exomiR-7972, a novel plant exosomal microRNA derived from fresh Rehmanniae Radix, ameliorated lipopolysaccharide-induced acute lung injury and gut dysbiosis

Fen-Sheng Qiu,Jia-Feng Wang,Mei-Ying Guo,Xue-Jian Li,Chang-Yi Shi,Fang Wu,Huan-Huan Zhang,Hua-Zhong Ying,Chen-Huan Yu

DOI: https://doi.org/10.1016/j.biopha.2023.115007

IF: 7.419

2023-09-01

Biomedicine & Pharmacotherapy

Abstract:Plant-derived exosome-like nanoparticles (ELNs) have been proposed as a novel therapeutic tool for preventing human diseases. However, the number of well-verified plant ELNs remains limited. In this study, the microRNAs in ELNs derived from fresh Rehmanniae Radix, a well-known traditional Chinese herb for treating inflammatory and metabolic diseases, were determined by using microRNA sequencing to investigate the active components in the ELNs and the protection against lipopolysaccharide (LPS)-induced acute lung inflammation in vivo and in vitro. The results showed that rgl-miR-7972 (miR-7972) was the main ingredient in ELNs. It exerted stronger protective activities against LPS-induced acute lung inflammation than catalpol and acteoside, which are two well-known chemical markers in this herb. Moreover, miR-7972 decreased the production of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α), reactive oxygen species (ROS) and nitric oxide (NO) in LPS-exposed RAW264.7 cells, thereby facilitating M2 macrophage polarization. Mechanically, miR-7972 downregulated the expression of G protein-coupled receptor 161 (GPR161), activating the Hedgehog pathway, and inhibited the biofilm form of Escherichia coli via targeting virulence gene sxt2. Therefore, miR-7972 derived from fresh R. Radix alleviated LPS-induced lung inflammation by targeting the GPR161-mediated Hedgehog pathway, recovering gut microbiota dysbiosis. It also provided a new direction for gaining novel bioactivity nucleic acid drugs and broadening the knowledge on cross-kingdom physiological regulation through miRNAs.

pharmacology & pharmacy,medicine, research & experimental

What problem does this paper attempt to address?

The paper aims to investigate the protective effects of exosome-like nanoparticles (ELNs) derived from Rehmanniae Radix and their microRNA (miR-7972) in lipopolysaccharide (LPS)-induced acute lung injury and gut microbiota dysbiosis. Specifically, the paper explores the following points:

1. **Identification of Active Components**: Using miRNA sequencing technology, the active miRNA components in Rehmanniae Radix ELNs were identified, with miR-7972 being determined as the main active component.

2. **In Vivo and In Vitro Experiments**: Through mouse models and cell experiments (such as RAW264.7 macrophages), the protective effects of miR-7972 on LPS-induced acute lung injury were studied. The results showed that miR-7972 significantly reduced the production of inflammatory cytokines (IL-1β, IL-6, and TNF-α) and promoted M2 macrophage polarization.

3. **Mechanism Study**: It was found that miR-7972 downregulated the expression of G protein-coupled receptor 161 (GPR161), activated the Hedgehog pathway, thereby inhibiting the formation of Escherichia coli biofilms, and regulated the expression of its virulence gene sxt2.

4. **Gut Microbiota Remodeling**: The study also showed that miR-7972 could restore LPS-induced gut microbiota dysbiosis and might exert its protective effects by regulating the signaling between the host and microorganisms.

In summary, the paper aims to reveal the protective mechanisms of Rehmanniae Radix ELNs and their miR-7972 in acute lung injury and gut microbiota dysbiosis, providing new directions for the development of novel nucleic acid drugs.